This page summarises a third-party laboratory report that we hold. The report itself was produced for a sample submitted by another party and is not a Strata-manufactured document. We publish the verified figures and state plainly what the report does and does not show. Email or WhatsApp us if you need the report reference for your own due diligence.
Tirzepatide 60mg certificate of analysis
This is the Janoshik analytical report we hold for tirzepatide, task #78893, analysis conducted 17 June 2026. It records 64.78 mg (repeat 65.54 mg) at 99.923% (repeat 99.835%) purity on a third-party batch sample. The client name and verification key are covered; all reported figures and dates are unchanged from the laboratory.
Verified report details
- Task number
- Janoshik Analytical #78893
- Reported sample
- Batched sample labelled T60
- Reported by
- A third-party testing group, not Strata Peptides
- Reported manufacture
- a third-party manufacturer
- Analysis date
- 17 June 2026
- Analyte
- Tirzepatide
- Content per vial
- 64.78 mg (repeat 65.54 mg)
- Purity
- 99.923% (repeat 99.835%)
- Test requested
- Assessment of a peptide vial or vials
What this report does not show
This is a third-party analytical report on a batch sample. It does not verify the contents of any vial we ship today, and no Strata lot code appears on the laboratory document. Treat the figures as a reference point only and request current lot documentation before you rely on them.
Why this page shows figures rather than an image
We publish the recorded figures, the task number and the analysis date as text, so that you can read exactly what the report covers and what it does not. If you need the paperwork for the batch you are buying, ask us on WhatsApp and we will send what we hold for that lot.
Our purity guarantee
If your vial tests below 99% purity at an independent laboratory, we refund the order in full. That promise is ours and does not depend on this reference report. See current terms.